These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 140441

  • 1. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I, Diumenjo M.
    Rev Clin Esp; 1977 Mar 31; 144(6):403-9. PubMed ID: 140441
    [No Abstract] [Full Text] [Related]

  • 2. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA, Good RA.
    Hum Pathol; 1974 Sep 31; 5(5):567-99. PubMed ID: 4137052
    [No Abstract] [Full Text] [Related]

  • 3. [Immunological behavior of patients with malignant blood diseases].
    Luca N.
    Stud Cercet Med Interna; 1973 Sep 31; 14(5):429-46. PubMed ID: 4202394
    [No Abstract] [Full Text] [Related]

  • 4. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S, Gociu M.
    Stud Cercet Med Interna; 1969 Sep 31; 10(3):197-208. PubMed ID: 4186583
    [No Abstract] [Full Text] [Related]

  • 5. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP, Fernandes B.
    Schweiz Med Wochenschr; 1975 Sep 13; 105(37):1174-9. PubMed ID: 814616
    [Abstract] [Full Text] [Related]

  • 6. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G, Petrini MT, Tognella S, Grifoni V.
    Boll Soc Ital Biol Sper; 1972 Jul 30; 48(14):381-5. PubMed ID: 4628299
    [No Abstract] [Full Text] [Related]

  • 7. [Immunology of lymphocytes in leukemia].
    Astaldi G, Astaldi GC.
    Recenti Prog Med; 1975 Sep 30; 59(3):248-65. PubMed ID: 131361
    [No Abstract] [Full Text] [Related]

  • 8. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E.
    Rinsho Ketsueki; 1976 Jun 30; 17(6):600-17. PubMed ID: 823349
    [No Abstract] [Full Text] [Related]

  • 9. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A, Tarocco RP, Nicola P.
    Minerva Pediatr; 1970 Dec 22; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract] [Full Text] [Related]

  • 10. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P, Thivolet J, Alario A, Schmitt D, Perrot H.
    Dermatologica; 1978 Dec 22; 157(5):268-81. PubMed ID: 150348
    [Abstract] [Full Text] [Related]

  • 11. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F, Lacava V, Fiorilli M, Ciarla MV.
    Acta Haematol; 1973 Dec 22; 50(5):275-83. PubMed ID: 4202631
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC, Flandrin G.
    Bull Cancer; 1977 Dec 22; 64(2):267-74. PubMed ID: 143976
    [Abstract] [Full Text] [Related]

  • 13. Editorial: Sézary syndrome.
    Br Med J; 1975 Mar 15; 1(5958):590-1. PubMed ID: 123808
    [No Abstract] [Full Text] [Related]

  • 14. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
    Seligmann M, Preud'Homme JL, Brouet JC.
    Transplant Rev; 1973 Mar 15; 16():85-113. PubMed ID: 4204588
    [No Abstract] [Full Text] [Related]

  • 15. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E, San Miguel JF, Catovsky D.
    Med Clin (Barc); 1983 Mar 05; 80(7):334-50. PubMed ID: 6406774
    [No Abstract] [Full Text] [Related]

  • 16. [Immunological deficiency in various disorders of lymphoreticular system].
    Frydecka I.
    Pol Tyg Lek; 1977 May 30; 32(22):851-3. PubMed ID: 407553
    [No Abstract] [Full Text] [Related]

  • 17. Immune deficiency states associated with malignant disease in man.
    Harris J, Bagai RC.
    Med Clin North Am; 1972 Mar 30; 56(2):501-14. PubMed ID: 4623010
    [No Abstract] [Full Text] [Related]

  • 18. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP, Petrányi G, Hollán Z.
    Orv Hetil; 1974 Apr 21; 115(16):930-1. PubMed ID: 4206891
    [No Abstract] [Full Text] [Related]

  • 19. Cellular structure and function in normal and neoplastic lymphoid cells.
    Zucker-Franklin D.
    Arch Intern Med; 1975 Jan 21; 135(1):55-60. PubMed ID: 163073
    [Abstract] [Full Text] [Related]

  • 20. The spectrum of B cell neoplasia.
    Deegan MJ.
    Henry Ford Hosp Med J; 1984 Jan 21; 32(1):20-30. PubMed ID: 6204956
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.